Page last updated: 2024-08-25

Tormentic acid and Parkinson Disease

Tormentic acid has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Jiang, X; Qiao, B; Yue, Y	1

Other Studies

1 other study(ies) available for Tormentic acid and Parkinson Disease

Article	Year
Tormentic acid confers protection against oxidative stress injury in rats with Parkinson's disease by targeting the Wnt/β-catenin signaling pathway. Cellular and molecular biology (Noisy-le-Grand, France), 2020, Apr-20, Volume: 66, Issue:1 Topics: Animals; Behavior, Animal; Cell Survival; Female; Glutathione Peroxidase; Male; Malondialdehyde; Memory; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; PC12 Cells; Rats; Rats, Wistar; RNA, Messenger; Superoxide Dismutase; Triterpenes; Wnt Signaling Pathway	2020

Article

Year

Tormentic acid confers protection against oxidative stress injury in rats with Parkinson's disease by targeting the Wnt/β-catenin signaling pathway.

Cellular and molecular biology (Noisy-le-Grand, France), 2020, Apr-20, Volume: 66, Issue:1

Topics: Animals; Behavior, Animal; Cell Survival; Female; Glutathione Peroxidase; Male; Malondialdehyde; Memory; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; PC12 Cells; Rats; Rats, Wistar; RNA, Messenger; Superoxide Dismutase; Triterpenes; Wnt Signaling Pathway

2020